Lagophthalmos - Causes, Treatment & When to See a Doctor

What is Lagophthalmos?

Lagophthalmos (pronounced lag‑oh‑fthuh‑MOH‑suhs) is the medical term for the inability to close one or both eyes completely. When the eyelids cannot meet, the surface of the eye (the cornea and conjunctiva) is exposed to air, leading to dryness, irritation, and, if untreated, potentially serious damage.

The condition may be present all the time (persistent lagophthalmos) or only during certain activities such as sleep (nocturnal lagophthalmos). It is a symptom rather than a disease itself, reflecting an underlying problem with the muscles, nerves, or structures that control eyelid closure.

Sources: Mayo Clinic ¹; American Academy of Ophthalmology ².

Common Causes

Lagophthalmos can arise from a wide range of neurological, muscular, traumatic, or systemic conditions. The most frequently encountered causes include:

• Facial nerve (VII) palsy – Bell’s palsy, stroke‑related palsy, or surgical injury to the facial nerve can paralyze the orbicularis oculi muscle, which closes the eyelid.
• Exophthalmos (proptosis) – Conditions that push the eye forward, such as Graves’ disease, orbital tumors, or orbital cellulitis, can prevent the lids from covering the globe.
• Trauma or surgery – Fractures of the orbital rim, eyelid lacerations, or cosmetic/plastic surgery may disrupt eyelid mechanics.
• Neuromuscular disorders – Myasthenia gravis, Lambert‑Eaton syndrome, and facial dystonias can impair the strength or coordination of eyelid muscles.
• Scarring or contracture – Burns, radiation therapy, or chronic inflammatory skin diseases (e.g., scleroderma) can cause tight scar tissue that limits lid movement.
• Congenital abnormalities – Birth defects such as Marcus Gunn jaw‑winking syndrome or congenital facial nerve agenesis may present early with lagophthalmos.
• Sleep‑related factors – Nighttime dryness, sleep apnea, or use of continuous positive airway pressure (CPAP) masks can worsen nocturnal lagophthalmos.
• Medication side‑effects – Certain anticholinergics, muscle relaxants, or chemotherapeutic agents can reduce tear production and weaken eyelid closure.
• Systemic diseases – Diabetes mellitus (via neuropathy), multiple sclerosis, or Guillain‑Barré syndrome can involve the facial nerve.
• Age‑related changes – In older adults, laxity of eyelid skin and decreased muscle tone increase the risk of incomplete closure, especially during sleep.

Associated Symptoms

Because the cornea is left exposed, patients often report a constellation of eye‑related complaints:

• Dryness, gritty or sand‑like sensation
• Redness and mild swelling of the conjunctiva (conjunctival injection)
• Excessive tearing (reflex tearing) – paradoxical but common
• Blurred vision, especially after waking
• Eye fatigue or soreness after reading or screen use
• Photophobia (sensitivity to light)
• Development of corneal abrasions, ulcers, or stromal scarring if untreated
• Involuntary eyelid twitching (if muscle irritation is present)

When to See a Doctor

Although mild dryness can often be managed with over‑the‑counter lubricants, lagophthalmos warrants prompt evaluation when any of the following occur:

• Persistent eye pain or a foreign‑body sensation that does not improve with artificial tears.
• Redness that spreads or is accompanied by discharge (possible infection).
• Sudden decrease in visual acuity, double vision, or persistent blurry vision.
• Visible cracks or ulcers on the cornea noted by an eye‑care professional.
• Associated facial weakness, numbness, or drooping that suggests a facial nerve problem.
• Symptoms that worsen after sleep, indicating nocturnal lagophthalmos.

Early ophthalmology referral can prevent permanent corneal damage and preserve vision.

Diagnosis

Evaluation of lagophthalmos is multidisciplinary, often involving primary‑care physicians, neurologists, and ophthalmologists.

Clinical examination

• Inspection – The clinician observes the eyelids in repose and during attempted closure, noting any gap (typically measured in millimeters).
• Fluorescein staining – A drop of fluorescein dye highlights corneal epithelial defects under a cobalt‑blue light.
• Schirmer test or tear film breakup time – Determines whether dry eye is contributing to symptoms.

Neurological assessment

• Facial nerve function grading (e.g., House‑Brackmann scale).
• Electromyography (EMG) or nerve conduction studies if a neuropathy is suspected.

Imaging

• CT or MRI of the orbit and brain – Detects orbital masses, fractures, or central lesions affecting the facial nerve.
• Ultrasound of the eyelid – Helps evaluate scar tissue or muscle atrophy.

Laboratory work‑up may be ordered when systemic disease is suspected (e.g., thyroid function tests for Graves’ disease, autoimmune panels for myasthenia gravis).

Treatment Options

Management is tailored to the underlying cause, severity of corneal exposure, and patient-specific factors.

Conservative / Home Care

• Lubricating eye drops – Preservative‑free artificial tears applied 4‑6 times daily.
• Ophthalmic ointments – Thick, nighttime ointments (e.g., erythromycin‑containing) protect the cornea while sleeping.
• Moisture goggles or eye shields – Silicone or moisture‑retaining goggles worn during sleep or in dry environments.
• Humidifiers – Increase ambient humidity, especially in winter months.
• Eyelid taping – Gentle medical tape can temporarily keep lids closed at night; avoid excessive tension.

Medical Interventions

• Botulinum toxin (Botox) injections – For facial nerve hyper‑activity causing incomplete closure (e.g., synkinesis).
• Corticosteroids – Short courses for acute inflammatory facial palsy (e.g., Bell’s palsy) to reduce nerve swelling.
• Systemic treatment of underlying disease – Antithyroid meds for Graves’ disease, immunotherapy for myasthenia gravis, etc.

Surgical Options

When conservative measures fail or corneal risk is high, surgery may be indicated:

• Lateral tarsorrhaphy – Suturing the outer eyelid margins together partially or completely to narrow the palpebral fissure.
• Gold or platinum eyelid weight implantation – A small weighted implant placed in the upper eyelid helps it close passively with gravity.
• Temporalis muscle transfer – The temporalis tendon is redirected to the eyelid to provide active closure in severe facial palsy.
• Mid‑face lift or sling procedures – Re‑suspends lax eyelid tissues in elderly patients.

Post‑operative care includes continued lubrication and regular follow‑up to adjust sutures or assess implant position.

Prevention Tips

While not all causes are preventable, several strategies can reduce the risk of developing lagophthalmos or lessen its impact:

• Prompt treatment of facial nerve injuries or Bell’s palsy (ideally within 72 hours).
• Maintain good eyelid hygiene; avoid chronic irritation from cosmetics or contact lenses.
• Use protective eyewear during activities that pose orbital trauma (e.g., sports, machinery).
• Manage systemic diseases (thyroid control, diabetes management) to limit secondary nerve damage.
• For patients with known exophthalmos, regular ophthalmology visits to monitor corneal exposure.
• Keep home humidity at 40–60 % in dry climates and use air‑purifying humidifiers at night.
• Educate caregivers of elderly or neurologically impaired individuals on nightly eyelid taping or moisture goggles.

Emergency Warning Signs

Seek immediate medical attention (ER or urgent ophthalmology) if you experience any of the following:

• Severe, sudden eye pain or a burning sensation that does not improve with lubricants.
• Rapid loss of vision or a marked decrease in visual acuity.
• Visible white spot, ulcer, or blackened area on the cornea (possible ulceration).
• Profuse discharge (yellow/green) indicating infection.
• Facial droop accompanied by difficulty speaking, swallowing, or eye movement—possible stroke or severe nerve palsy.

References:

1. Mayo Clinic. “Lagophthalmos.” Updated 2023. https://www.mayoclinic.org
2. American Academy of Ophthalmology. “Management of Exposure Keratopathy.” 2022. https://www.aao.org
3. National Eye Institute. “Dry Eye.” 2021. https://www.nei.nih.gov
4. Cleveland Clinic. “Bell’s Palsy.” 2024. https://my.clevelandclinic.org
5. World Health Organization. “Thyroid Eye Disease.” 2023. https://www.who.int